Format

Send to

Choose Destination
Haematologica. 2019 Apr 4. pii: haematol.2018.215236. doi: 10.3324/haematol.2018.215236. [Epub ahead of print]

Response assessment in acute myeloid leukemia by flow cytometry supersedes cytomorphology at time of aplasia, amends cases without molecular residual disease marker and serves as an independent prognostic marker at time of aplasia and post-induction.

Author information

1
Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich.
2
Institute of Biostatistics and Clinical Research, University of Münster, Germany.
3
Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich; marion.subklewe@med.uni-muenchen.de.

KEYWORDS:

Acute Myeloid Leukemia; Flow Cytometry; Minimal Residual Disease

PMID:
30948486
DOI:
10.3324/haematol.2018.215236
Free full text

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center